Ayala Pharmaceuticals Inc (ADXS)

[hovacre]

Where the f*k is AMGN $500M deal money????

Ken dropped a hint here, that the milestones are downstream in the clinical development of NEO. At this point, given the lack of a milestone payment upon initiation of the first patient, my presumption becomes that the milestone payment will come upon establishment of proof of concept, at which point they turn over development to AMGN, somewhat similar to the GERN-JNJ deal.